World Library  
Flag as Inappropriate
Email this Article

Remoxipride

Article Id: WHEBN0006144162
Reproduction Date:

Title: Remoxipride  
Author: World Heritage Encyclopedia
Language: English
Subject: Antipsychotic, Tiapride, Butaclamol, Spiramide, Gevotroline
Collection: Atypical Antipsychotics, Benzamides, Organobromides, Phenol Ethers, Pyrrolidines, Withdrawn Drugs
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Remoxipride

Remoxipride
Systematic (IUPAC) name
(S)-3-bromo-N-[(1-ethylpyrrolidin-2-yl)methyl]-2,6-dimethoxy-benzamide
Clinical data
Trade names Roxiam
Legal status
  • Withdrawn
Routes of
administration
Oral
Pharmacokinetic data
Bioavailability 96%[1]
Protein binding 89-98%
Metabolism Hepatic[1]
Biological half-life 4-7 hours[1]
Excretion Renal[1]
Identifiers
CAS Registry Number  N
ATC code N05
PubChem CID:
DrugBank  YesY
ChemSpider  YesY
UNII  YesY
KEGG  YesY
ChEMBL  YesY
Chemical data
Formula C16H23BrN2O3
Molecular mass 371.27 g/mol
 N   

Remoxipride (Roxiam) is an atypical antipsychotic (although according to some sources it is a typical antipsychotic) which was previously used in Europe for the treatment of schizophrenia and acute mania but was withdrawn due to toxicity concerns (incidence of aplastic anemia in 1/10,000 patients).[2] It was initially launched by AstraZeneca in 1990 and suspension of its use began in 1993.[2] Remoxipride acts as a selective D2 and D3 receptor antagonist and also has high affinity for the sigma receptor, possibly playing a role in its atypical neuroleptic action.[3]

Due to its short half-life twice daily (bid) dosing is required, although a once-daily controlled-release tablet has been developed.[4] There was some interest in its use in the treatment of treatment-resistant schizophrenia.[5][6]

See also

References

  1. ^ a b c d
  2. ^ a b
  3. ^
  4. ^
  5. ^
  6. ^

External links

  • Herbert Y. Meltzer, Atypical Antipsychotic Drugs, 2000



This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.